Marcus Flather
Cited by
Cited by
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
New England Journal of Medicine 345 (7), 494-502, 2001
Heart disease and stroke statistics-2003 update
American Heart Association
http://www. americanheart. org/downloadable/heart …, 2002
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ...
New England Journal of Medicine 354 (16), 1706-1717, 2006
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ...
Archives of internal medicine 163 (19), 2345-2353, 2003
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
MD Flather, MC Shibata, AJS Coats, DJ Van Veldhuisen, A Parkhomenko, ...
European heart journal 26 (3), 215-225, 2005
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ...
The Lancet 355 (9215), 1575-1581, 2000
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association …
V Fuster, LE Rydén, RW Asinger, DS Cannom, HJ Crijns, RL Frye, ...
Journal of the American College of Cardiology 38 (4), 1231-1265, 2001
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry
KA Eagle, MJ Lim, OH Dabbous, KS Pieper, RJ Goldberg, F Van de Werf, ...
Jama 291 (22), 2727-2733, 2004
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
KAA Fox, OH Dabbous, RJ Goldberg, KS Pieper, KA Eagle, F Van de Werf, ...
bmj 333 (7578), 1091, 2006
European Society of Cardiology: cardiovascular disease statistics 2019
A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ...
European heart journal 41 (1), 12-85, 2020
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials …
PR Collins R, Flather M, Parish S, Baigent C
The Lancet 343, 311-322, 1994
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis …
L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ...
The Lancet 376 (9745), 975-983, 2010
Apixaban with antiplatelet therapy after acute coronary syndrome
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine 365 (8), 699-708, 2011
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
KAA Fox, PG Steg, KA Eagle, SG Goodman, FA Anderson, CB Granger, ...
Jama 297 (17), 1892-1900, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ...
Journal of the American College of Cardiology 49 (19), 1982-1988, 2007
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten …
MA Hlatky, DB Boothroyd, DM Bravata, E Boersma, J Booth, MM Brooks, ...
The Lancet 373 (9670), 1190-1197, 2009
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and Non-Q-Wave mayocardial infarction
Prism-Plus Study Investigators
N Engl J Med 338, 1488-1497, 1998
The system can't perform the operation now. Try again later.
Articles 1–20